Selvita S.A. (WSE:SLV)

Poland flag Poland · Delayed Price · Currency is PLN
33.00
+0.10 (0.30%)
May 28, 2025, 4:43 PM CET
-50.82%
Market Cap 600.22M
Revenue (ttm) 359.79M
Net Income (ttm) -4.95M
Shares Out 18.36M
EPS (ttm) -0.27
PE Ratio n/a
Forward PE 25.85
Dividend n/a
Ex-Dividend Date n/a
Volume 32,303
Average Volume 23,702
Open 33.00
Previous Close 32.90
Day's Range 32.90 - 34.40
52-Week Range 29.90 - 69.90
Beta 0.08
RSI 46.86
Earnings Date May 22, 2025

About Selvita

Selvita S.A. operates as a contract research organization worldwide. The company offers drug discovery services in the areas of AI-driven drug discovery, antibody drug discovery, structural biology, recombinant protein production, assay development and screening, computer-aided drug design, medicinal and synthetic chemistry, scale-up, ADME/DMPK, in vitro and In Vivo pharmacology, translational research, and toxicology. It also develops drugs for therapeutic areas, such as oncology, infectious diseases, immunology, neurology, respiratory, and ot... [Read more]

Sector Healthcare
Founded 2007
Employees 969
Stock Exchange Warsaw Stock Exchange
Ticker Symbol SLV
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.